Cargando…
The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics
One of the main challenges in proteomics lies in obtaining a high level of reproducible fractionation of the protein samples. Automated two-dimensional liquid phase fractionation (PF2D) system manufactured by Beckman Coulter provides a process well suited for proteome studies. However, the protein r...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196251/ https://www.ncbi.nlm.nih.gov/pubmed/22013380 http://dx.doi.org/10.1155/2011/213643 |
_version_ | 1782214198787309568 |
---|---|
author | Kim, Mina Lee, Sang-Hee Min, Jiho Kobayashi, Fumihisa Um, Hyun-Ju Kim, Yang-Hoon |
author_facet | Kim, Mina Lee, Sang-Hee Min, Jiho Kobayashi, Fumihisa Um, Hyun-Ju Kim, Yang-Hoon |
author_sort | Kim, Mina |
collection | PubMed |
description | One of the main challenges in proteomics lies in obtaining a high level of reproducible fractionation of the protein samples. Automated two-dimensional liquid phase fractionation (PF2D) system manufactured by Beckman Coulter provides a process well suited for proteome studies. However, the protein recovery efficiency of such system is low when a protocol recommended by the manufacturer is used for metaproteome profiling of environmental sample. In search of an alternative method that can overcome existing limitations, this study replaced manufacturer's buffers with Triton X-100 during the PF2D evaluation of Escherichia coli K12. Three different Triton X-100 concentrations—0.1%, 0.15%, and 0.2%—were used for the first-dimension protein profiling. As the first-dimension result was at its best in the presence of 0.15% Triton X-100, second-dimension protein fractionation was performed using 0.15% Triton X-100 and the standard buffers. When 0.15% Triton X-100 was used, protein recovery increased as much as tenfold. The elution reliability of 0.15% Triton X-100 determined with ribonuclease A, insulin, α-lactalbumin, trypsin inhibitor, and cholecystokinin (CCK) affirmed Triton X-100 at 15% can outperform the standard buffers without having adverse effects on samples. This novel use of 0.15% Triton X-100 for PF2D can lead to greater research possibilities in the field of proteomics. |
format | Online Article Text |
id | pubmed-3196251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-31962512011-10-19 The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics Kim, Mina Lee, Sang-Hee Min, Jiho Kobayashi, Fumihisa Um, Hyun-Ju Kim, Yang-Hoon J Biomed Biotechnol Research Article One of the main challenges in proteomics lies in obtaining a high level of reproducible fractionation of the protein samples. Automated two-dimensional liquid phase fractionation (PF2D) system manufactured by Beckman Coulter provides a process well suited for proteome studies. However, the protein recovery efficiency of such system is low when a protocol recommended by the manufacturer is used for metaproteome profiling of environmental sample. In search of an alternative method that can overcome existing limitations, this study replaced manufacturer's buffers with Triton X-100 during the PF2D evaluation of Escherichia coli K12. Three different Triton X-100 concentrations—0.1%, 0.15%, and 0.2%—were used for the first-dimension protein profiling. As the first-dimension result was at its best in the presence of 0.15% Triton X-100, second-dimension protein fractionation was performed using 0.15% Triton X-100 and the standard buffers. When 0.15% Triton X-100 was used, protein recovery increased as much as tenfold. The elution reliability of 0.15% Triton X-100 determined with ribonuclease A, insulin, α-lactalbumin, trypsin inhibitor, and cholecystokinin (CCK) affirmed Triton X-100 at 15% can outperform the standard buffers without having adverse effects on samples. This novel use of 0.15% Triton X-100 for PF2D can lead to greater research possibilities in the field of proteomics. Hindawi Publishing Corporation 2011 2011-10-16 /pmc/articles/PMC3196251/ /pubmed/22013380 http://dx.doi.org/10.1155/2011/213643 Text en Copyright © 2011 Mina Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kim, Mina Lee, Sang-Hee Min, Jiho Kobayashi, Fumihisa Um, Hyun-Ju Kim, Yang-Hoon The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics |
title | The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics |
title_full | The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics |
title_fullStr | The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics |
title_full_unstemmed | The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics |
title_short | The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics |
title_sort | utilization of triton x-100 for enhanced two-dimensional liquid-phase proteomics |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196251/ https://www.ncbi.nlm.nih.gov/pubmed/22013380 http://dx.doi.org/10.1155/2011/213643 |
work_keys_str_mv | AT kimmina theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics AT leesanghee theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics AT minjiho theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics AT kobayashifumihisa theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics AT umhyunju theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics AT kimyanghoon theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics AT kimmina utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics AT leesanghee utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics AT minjiho utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics AT kobayashifumihisa utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics AT umhyunju utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics AT kimyanghoon utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics |